AstraZeneca (AZN) News Today $70.76 -0.21 (-0.30%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$71.55 +0.79 (+1.12%) As of 05:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Buy" from AnalystsAstraZeneca PLC (NASDAQ:AZN - Get Free Report) has been assigned a consensus recommendation of "Buy" from the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have given a buy rating and two have giJune 20 at 2:22 AM | marketbeat.com3,555 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Wolf Group Capital AdvisorsWolf Group Capital Advisors acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,555 shares of the company's stock, valued at apJune 19 at 4:50 AM | marketbeat.comProsperity Wealth Management Inc. Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Prosperity Wealth Management Inc. bought a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,785 shares of the company's stock, valued at approximateJune 19 at 4:41 AM | marketbeat.comJanney Montgomery Scott LLC Makes New $21.93 Million Investment in AstraZeneca PLC (NASDAQ:AZN)Janney Montgomery Scott LLC acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 298,310 shares of the company's stock, valued at approximatelyJune 18 at 4:14 AM | marketbeat.comDynamic Advisor Solutions LLC Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)Dynamic Advisor Solutions LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 58.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,055 shares of the company's stock after buying an additional 4,811 shaJune 18 at 3:49 AM | marketbeat.comTrump's big beautiful bill: What the pharma industry is watchingJune 17 at 5:49 PM | finance.yahoo.comInscription Capital LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Inscription Capital LLC purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,284 shares of the company's stock, valued aJune 17 at 5:29 AM | marketbeat.comQRG Capital Management Inc. Has $17.30 Million Position in AstraZeneca PLC (NASDAQ:AZN)QRG Capital Management Inc. raised its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 235,391 shares of the company's stock after puJune 17 at 4:43 AM | marketbeat.comMontecito Bank & Trust Purchases 4,328 Shares of AstraZeneca PLC (NASDAQ:AZN)Montecito Bank & Trust grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 104.1% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,484 shares of the company's stockJune 17 at 4:33 AM | marketbeat.comZacks Research Reduces Earnings Estimates for AstraZenecaJune 17 at 1:37 AM | americanbankingnews.comZacks Research Forecasts Weaker Earnings for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Investment analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for AstraZeneca in a research note issued to investors on Thursday, June 12th. Zacks Research analyst R. Department now forecasts that the company will postJune 16, 2025 | marketbeat.comRitholtz Wealth Management Acquires 7,101 Shares of AstraZeneca PLC (NASDAQ:AZN)Ritholtz Wealth Management grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 75,471 shares of the company's stock after purchJune 15, 2025 | marketbeat.comNorthCrest Asset Manangement LLC Has $1.40 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)NorthCrest Asset Manangement LLC lessened its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,087 shares of the company's stoJune 15, 2025 | marketbeat.comYousif Capital Management LLC Sells 4,845 Shares of AstraZeneca PLC (NASDAQ:AZN)Yousif Capital Management LLC trimmed its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,998 shares of the company's stock after selling 4,845 shares during theJune 15, 2025 | marketbeat.comNew England Research & Management Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN)New England Research & Management Inc. lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 159.3% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,950 shares of the company's stock aftJune 14, 2025 | marketbeat.comNew Century Financial Group LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)New Century Financial Group LLC reduced its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 75.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,846 shares of the company's stock after sellinJune 14, 2025 | marketbeat.comElevation Point Wealth Partners LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)Elevation Point Wealth Partners LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 23.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,075 shares of the company's stock afJune 14, 2025 | marketbeat.comAstraZeneca Inks $5.3B Deal With CSPC Pharma For Developing New Oral Drug Candidate, But Retail’s In No Mood To CheerJune 13, 2025 | msn.comStanley Laman Group Ltd. Purchases 9,614 Shares of AstraZeneca PLC (NASDAQ:AZN)Stanley Laman Group Ltd. increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 58,849 shares of the company's stock after buying an additional 9,614 sharesJune 13, 2025 | marketbeat.comAstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 BillionJune 13, 2025 | wsj.comAstraZeneca agrees to research deal worth up to $5.22 billion with CSPCJune 13, 2025 | reuters.comAssenagon Asset Management S.A. Sells 74,715 Shares of AstraZeneca PLC (NASDAQ:AZN)Assenagon Asset Management S.A. lowered its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.8% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 774,673 shares of the company's stock after selling 74,715 shares during the period. Assenagon AJune 12, 2025 | marketbeat.comI attended the world's biggest cancer conference. Doctors gave standing ovations to 2 major breakthroughs.June 11, 2025 | msn.comOak Family Advisors LLC Has $13.43 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)Oak Family Advisors LLC cut its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 182,742 shares of the company's stock after selling 16,961 shares during the quarter. AstrJune 10, 2025 | marketbeat.comWesbanco Bank Inc. Acquires 5,455 Shares of AstraZeneca PLC (NASDAQ:AZN)Wesbanco Bank Inc. boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,577 shares of the company's stock after purchasing an additionalJune 9, 2025 | marketbeat.comPark Avenue Securities LLC Has $6.54 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Park Avenue Securities LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 15.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,980 shares of the company's stock after acJune 9, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Professional Advisory Services Inc.Professional Advisory Services Inc. lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 305,433 shares of the company's stock after selling 27,512June 8, 2025 | marketbeat.comNBC Securities Inc. Purchases 3,837 Shares of AstraZeneca PLC (NASDAQ:AZN)NBC Securities Inc. increased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 95,925.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,841 shares of the company's stock after purchasing an additiJune 8, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Procyon Advisors LLCProcyon Advisors LLC boosted its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,854 shares of the company's stock after buying an additioJune 7, 2025 | marketbeat.comMerit Financial Group LLC Acquires 14,743 Shares of AstraZeneca PLC (NASDAQ:AZN)Merit Financial Group LLC boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 166.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,583 shares of the company's stock after purchasing an additional 14,743 shares during the perioJune 7, 2025 | marketbeat.comBreakwater Capital Group Takes Position in AstraZeneca PLC (NASDAQ:AZN)Breakwater Capital Group acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,837 shares of the company's stock, valued at approximately $429,000June 6, 2025 | marketbeat.comFermata Advisors LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)Fermata Advisors LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,986 shares of the company's stock, valued at approximately $293,0June 6, 2025 | marketbeat.comChesley Taft & Associates LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)Chesley Taft & Associates LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3,779.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 131,910 shares of the company's stock after purchasing an additional 128,510 shares duringJune 5, 2025 | marketbeat.comAstraZeneca rallies Wednesday, outperforms marketJune 4, 2025 | marketwatch.com74,997 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Nixon Peabody Trust Co.Nixon Peabody Trust Co. acquired a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 74,997 shares of the company's stock, valued at approxJune 4, 2025 | marketbeat.comGAMMA Investing LLC Buys 573,535 Shares of AstraZeneca PLC (NASDAQ:AZN)GAMMA Investing LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10,431.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 579,033 shares of the company's stock after purchasing an additional 573,535 sharesJune 4, 2025 | marketbeat.comAstraZeneca (LSE:AZN) Reports Positive Trial Results For ENHERTU® In Breast Cancer TreatmentJune 3, 2025 | finance.yahoo.comHealthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCOJune 3, 2025 | cnbc.comAstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCOJune 2, 2025 | finance.yahoo.comHow AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion PharmaJune 2, 2025 | investors.comBlood test-guided treatment with AstraZeneca pill cuts breast cancer progression riskJune 1, 2025 | msn.comDATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung CancerJune 1, 2025 | finance.yahoo.comBlood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study findsJune 1, 2025 | reuters.comCamizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trialJune 1, 2025 | businesswire.comAstraZeneca PLC (NASDAQ:AZN) Position Increased by Wealth Enhancement Advisory Services LLCWealth Enhancement Advisory Services LLC increased its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 59.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 306,043 shares of the company's stock afterJune 1, 2025 | marketbeat.comToronto Dominion Bank Acquires 9,151 Shares of AstraZeneca PLC (NASDAQ:AZN)Toronto Dominion Bank grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 51.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 27,080 shares of the company's stock after purchasing an additional 9,151 shares during thJune 1, 2025 | marketbeat.com183,548 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 183,548 shares of the comJune 1, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Short Interest UpdateAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 7,340,000 shares, a growth of 52.3% from the April 30th total of 4,820,000 shares. Currently, 0.2% of the company's shares are sold short. Based on an average trading volume of 5,990,000 shares, the short-interest ratio is presently 1.2 days.June 1, 2025 | marketbeat.comPfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progressionMay 31, 2025 | reuters.comVersant Capital Management Inc Buys 8,562 Shares of AstraZeneca PLC (NASDAQ:AZN)Versant Capital Management Inc grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1,166.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,296 shares of the company's stock after purchasing anMay 31, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.840.69▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2425▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts